Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Esparteiro, J
77  Ergebnisse:
Personensuche X
?
1

O-164 Live yeast supplementation during last month of gesta..:

Duniere, L. ; Esparteiro, D. ; Renaud, J....
Animal - science proceedings.  14 (2023)  1 - p. 178-179 , 2023
Link: https://doi.org/10.1016/..
 
?
2

EE50 What Is the Economic Impact of an Early Adoption of Hi..:

Gonçalves, N. ; Esparteiro, J. ; Barros, M.
Value in Health.  26 (2023)  12 - p. S59 , 2023
Link: https://doi.org/10.1016/..
 
?
3

EE129 Cost-Effectiveness of Ofatumumab Versus Ocrelizumab i..:

Gonçalves, N ; Esparteiro, J ; Machado, M..
Value in Health.  25 (2022)  12 - p. S78 , 2022
Link: https://doi.org/10.1016/..
 
?
4

PND20 Economic Savings from Delaying Time to Wheelchair wit..:

Bandeiras, C. ; Silva, C. ; Esparteiro, J....
Value in Health.  23 (2020)  - p. S625 , 2020
Link: https://doi.org/10.1016/..
 
?
5

PND37 Annual Cost of Acquisition of Disease Modifying Treat..:

Silva, C. ; Bandeiras, C. ; Costa, A...
Value in Health.  23 (2020)  - p. S629 , 2020
Link: https://doi.org/10.1016/..
 
?
6

PMS31 COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB IN ANKYLOS..:

Laires, P. ; Silva, C. ; Esparteiro, J..
Value in Health.  22 (2019)  - p. S699 , 2019
Link: https://doi.org/10.1016/..
 
?
7

PMS20 COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB IN ANKYLOS..:

Laires, P.A. ; Silva, C. ; Esparteiro, J..
Value in Health.  22 (2019)  - p. S697 , 2019
Link: https://doi.org/10.1016/..
 
?
8

PSS35 - SECUKINUMAB VERSUS USTEKINUMAB FOR THE TREATMENT OF..:

Laires, P.A. ; Silva, C. ; Esparteiro, J.
Value in Health.  21 (2018)  - p. S428 , 2018
Link: https://doi.org/10.1016/..
 
?
9

PMS48 - COST PER RESPONDER ANALYSIS FOLLOWING A 24-WEEK PSO..:

Silva, C. ; Esparteiro, J. ; Fonseca, A..
Value in Health.  21 (2018)  - p. S296 , 2018
Link: https://doi.org/10.1016/..
 
?
10

PMS42 - SECUKINUMAB VERSUS ADALIMUMAB FOR THE TREATMENT OF ..:

Laires, P.A. ; Esparteiro, J. ; Fonseca, A..
Value in Health.  21 (2018)  - p. S294-S295 , 2018
Link: https://doi.org/10.1016/..
 
?
11

PMS45 - COST PER RESPONDER ANALYSIS FOLLOWING A 48-WEEK PSO..:

Silva, C. ; Esparteiro, J. ; Fonseca, A..
Value in Health.  21 (2018)  - p. S295 , 2018
Link: https://doi.org/10.1016/..
 
?
12

PSS29 - SECUKINUMAB VERSUS ETANERCEPT FOR THE TREATMENT OF ..:

Esparteiro, J. ; Silva, C. ; Laires, P.A.
Value in Health.  21 (2018)  - p. S427 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Serum bile acids profiles are altered without change of the..:

Esparteiro, Damien ; Fouquet, Grégory ; Courtois, Anoïsia...
Gut Microbes.  16 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
14

Changes in Digestive Microbiota, Rumen Fermentations and Ox..:

Dunière, Lysiane ; Esparteiro, Damien ; Lebbaoui, Yacine...
Journal of Fungi.  7 (2021)  6 - p. 447 , 2021
Link: https://doi.org/10.3390/..
 
?
15

Promoting Regional Development Through a Collaborative Proj..:

, In: New Paths of Entrepreneurship Development; Studies on Entrepreneurship, Structural Change and Industrial Dynamics,
Saúde, Sandra ; Lopes, Sandra ; Piedade, Ana... - p. 207-227 , 2018
Link: https://doi.org/10.1007/..
 
1-15